Inhibition of amyloid formation may represent a promising therapeutic approach for the treatment of neurodegenerative diseases. To this regard, peptide-based inhibitors of Abeta aggregation have been widely investigated with a particular emphasis to those derived from original amyloid sequences. The experimental work described in the present PhD Thesis aims at outlining the molecular mechanisms underlying the antifibrillogenic and neuroprotective action exhibited by a new class of trehalose conjugated pentapeptides. Trehalose (Th), a non-reducing disaccharide of alpha-(D)glucose, has been demonstrated to be effective in preventing the aggregation of several proteins. We figured out that the development of hybrid compounds may provide new m...
Contains fulltext : 108708.pdf (Publisher’s version ) (Open Access)Current therape...
Amyloids result from the aggregation of a set of diverse proteins, due to either specific mutations ...
The amyloid peptides Abeta(40) and Abeta(42) of Alzheimer's disease are thought to contribute differ...
Aggregation of the amyloid A peptide and its accumulation into insoluble deposits (plaques) are beli...
Among the pathological hallmarks of Alzheimer\u27s disease (AD) is the deposition of amyloid-beta (A...
The Alzheimer's Association estimated this year that every 72 seconds, someone in America develops A...
International audienceHow anti-Alzheimer’s drug candidates that reduce amyloid 1–42 peptide fibrilli...
Alzheimer's disease (AD) is a progressive neurodegenerative disorder. The 'amyloid cascade hypothesi...
Extracellular fibrillar amyloid deposits are prominent and universal Alzheimer's disease (AD) featur...
Alzheimer\u27s disease (AD) is characterized by the cerebral accumulation of misfolded and aggregate...
The self-assembly of two derivatives of KLVFF, a fragment Abeta(16-20) of the amyloid beta (Abeta) p...
How anti-Alzheimer’s drug candidates that reduce amyloid 1–42 peptide fibrillization interact with t...
BACKGROUND: Alzheimer's disease is the most common neurodegenerative disease associated with aggrega...
Amyloid fibrils associated with Alzheimer's disease and a wide range of other neurodegenerative dise...
Alzheimer’s disease (AD) is the most common cause of senile dementia worldwide. AD is a neurodegener...
Contains fulltext : 108708.pdf (Publisher’s version ) (Open Access)Current therape...
Amyloids result from the aggregation of a set of diverse proteins, due to either specific mutations ...
The amyloid peptides Abeta(40) and Abeta(42) of Alzheimer's disease are thought to contribute differ...
Aggregation of the amyloid A peptide and its accumulation into insoluble deposits (plaques) are beli...
Among the pathological hallmarks of Alzheimer\u27s disease (AD) is the deposition of amyloid-beta (A...
The Alzheimer's Association estimated this year that every 72 seconds, someone in America develops A...
International audienceHow anti-Alzheimer’s drug candidates that reduce amyloid 1–42 peptide fibrilli...
Alzheimer's disease (AD) is a progressive neurodegenerative disorder. The 'amyloid cascade hypothesi...
Extracellular fibrillar amyloid deposits are prominent and universal Alzheimer's disease (AD) featur...
Alzheimer\u27s disease (AD) is characterized by the cerebral accumulation of misfolded and aggregate...
The self-assembly of two derivatives of KLVFF, a fragment Abeta(16-20) of the amyloid beta (Abeta) p...
How anti-Alzheimer’s drug candidates that reduce amyloid 1–42 peptide fibrillization interact with t...
BACKGROUND: Alzheimer's disease is the most common neurodegenerative disease associated with aggrega...
Amyloid fibrils associated with Alzheimer's disease and a wide range of other neurodegenerative dise...
Alzheimer’s disease (AD) is the most common cause of senile dementia worldwide. AD is a neurodegener...
Contains fulltext : 108708.pdf (Publisher’s version ) (Open Access)Current therape...
Amyloids result from the aggregation of a set of diverse proteins, due to either specific mutations ...
The amyloid peptides Abeta(40) and Abeta(42) of Alzheimer's disease are thought to contribute differ...